Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Melanoma

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 63 articles: HTML format

Single Articles

November 2024
1. LOURDAULT K, Cowman AW, Hanes D, Scholer AJ, et al
   Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?
   J Surg Oncol. 2024 Nov 17. doi: 10.1002/jso.27976.
   PubMed     Abstract available
   
   
   October 2024
2. YEE EJ, Thielen ON, Truong R, Gilbert D, et al
   Metastatic Melanoma to the Small Bowel and Colon: A Systematic Review of the Global Experience and Institutional Cohort Analysis Detailing a Rare Clinical Entity.
   J Surg Oncol. 2024 Oct 28. doi: 10.1002/jso.27958.
   PubMed     Abstract available
   
   
   
3. DRUSKOVICH C, Kelley J, Aubrey J, Palladino L, et al
   A Review of Melanoma Subtypes: Genetic and Treatment Considerations.
   J Surg Oncol. 2024 Oct 16. doi: 10.1002/jso.27953.
   PubMed     Abstract available
   
   
   
4. DHEER A, Tortorello GN, Shafique N, Farooq MS, et al
   Sequencing of Immunotherapy and Outcomes in Operable Clinical Stage III Melanoma: A National Cohort Study.
   J Surg Oncol. 2024 Oct 3. doi: 10.1002/jso.27933.
   PubMed     Abstract available
   
   
   September 2024
5. LI J, Cheng W
   Letter Regarding "Factors Associated With Skeletal-Related Events in Patients With Bone Metastatic Melanoma: A Retrospective Study of 481 Patients".
   J Surg Oncol. 2024 Sep 30. doi: 10.1002/jso.27915.
   PubMed    
   
   
   August 2024
6. FANNING JE, Singhal D, Reynolds HM, Don TDJ, et al
   Patterns of forearm lymphatic drainage to the epitrochlear lymph nodes in 1400 cutaneous melanoma patients.
   J Surg Oncol. 2024 Aug 13. doi: 10.1002/jso.27811.
   PubMed     Abstract available
   
   
   
7. SANTOS RLD, Martins MR, Tavares VL, Neto JPD, et al
   Analysis of the expression of cytokines and chemokines, platelet-leukocyte aggregates, sCD40L and sCD62P in cutaneous melanoma.
   J Surg Oncol. 2024 Aug 11. doi: 10.1002/jso.27748.
   PubMed     Abstract available
   
   
   June 2024
8. SHIMIZU MR, de Groot TM, Twining PK, Kobes T, et al
   Factors associated with skeletal-related events in patients with bone metastatic melanoma: A retrospective study of 481 patients.
   J Surg Oncol. 2024 Jun 17. doi: 10.1002/jso.27731.
   PubMed     Abstract available
   
   
   May 2024
9. GREENE AC, Matzelle-Zywicki M, Ziegler O, El-Mallah JC, et al
   Characteristics and variations in young adults with cutaneous melanoma: A national cancer database analysis.
   J Surg Oncol. 2024 May 19. doi: 10.1002/jso.27685.
   PubMed     Abstract available
   
   
   
10. PARKER LM, Beekman KE, DePalo DK, Elleson KM, et al
    Evaluating the role of level 3 axillary lymph node dissection in metastatic melanoma: Can we predict involvement?
    J Surg Oncol. 2024 May 8. doi: 10.1002/jso.27664.
    PubMed     Abstract available
    
    
    March 2024
11. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    A national database analysis of the evolution of outcomes of surgery for anal melanoma.
    J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27631.
    PubMed     Abstract available
    
    
    
12. STEADMAN JA, Glasgow AE, Neequaye NN, Habermann EB, et al
    Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27608.
    PubMed     Abstract available
    
    
    
13. KADHUM M, Mayr L, Pope-Jones S, Cubitt J, et al
    Sentinel lymph node biopsy for melanoma in the older population: A prospective analysis of outcomes.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27617.
    PubMed     Abstract available
    
    
    November 2023
14. MALEKZADEH P, Brady MS
    Adjuvant therapy for stage IIB + IIC melanoma.
    J Surg Oncol. 2023 Nov 30. doi: 10.1002/jso.27534.
    PubMed    
    
    
    
15. KAKISH H, Lal T, Thuener JE, Bordeaux JS, et al
    Is sentinel lymph node biopsy needed for lentigo maligna melanoma?
    J Surg Oncol. 2023 Nov 29. doi: 10.1002/jso.27543.
    PubMed     Abstract available
    
    
    
16. GOYAL A, Fei-Zhang DJ, Pawlik TM, Bentrem DJ, et al
    Associations of social vulnerability with truncal and extremity melanomas in the United States.
    J Surg Oncol. 2023 Nov 27. doi: 10.1002/jso.27532.
    PubMed     Abstract available
    
    
    
17. KAKISH H, Drigotas C, Ahmed FA, Elshami M, et al
    The effect of surgical timing in nonmetastatic melanoma.
    J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27507.
    PubMed     Abstract available
    
    
    
18. ASAI Y, Yanagawa N, Osakabe M, Yamada N, et al
    The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma.
    J Surg Oncol. 2023 Nov 2. doi: 10.1002/jso.27487.
    PubMed     Abstract available
    
    
    September 2023
19. LIN X, Sun W, Ren M, Xu Y, et al
    Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes.
    J Surg Oncol. 2023 Sep 10. doi: 10.1002/jso.27438.
    PubMed     Abstract available
    
    
    July 2023
20. FASTNER S, Hieken TJ, McWilliams RR, Hyngstrom J, et al
    Anorectal melanoma.
    J Surg Oncol. 2023 Jul 3. doi: 10.1002/jso.27381.
    PubMed     Abstract available
    
    
    April 2023
21. ASARE EA, Fisher SB, Chiang YJ, Haydu LE, et al
    Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management.
    J Surg Oncol. 2023 Apr 3. doi: 10.1002/jso.27267.
    PubMed     Abstract available
    
    
    March 2023
22. HOLTKAMP LHJ, Lo SN, Thompson JF, Spillane AJ, et al
    Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection.
    J Surg Oncol. 2023 Mar 27. doi: 10.1002/jso.27245.
    PubMed     Abstract available
    
    
    
23. SANTAMARIA-BARRIA JA, Matsuba C, Khader A, Scholar AJ, et al
    Age-related next-generation sequencing mutational analysis in 1196 melanomas.
    J Surg Oncol. 2023 Mar 20. doi: 10.1002/jso.27239.
    PubMed     Abstract available
    
    
    
24. HOSEIN S, Drebin HM, Kurtansky NR, Olofsson Bagge R, et al
    Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
    J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27231.
    PubMed     Abstract available
    
    
    December 2022
25. LEONARD LD, Beaty L, Thomas M, Quinn C, et al
    Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma.
    J Surg Oncol. 2022 Dec 1. doi: 10.1002/jso.27153.
    PubMed     Abstract available
    
    
    November 2022
26. LI WY
    The role of electrochemotherapy in dermal metastases.
    J Surg Oncol. 2022;126:1148.
    PubMed    
    
    
    October 2022
27. COIT DG, Ariyan CE
    Fifty years of progress in surgical oncology: Melanoma.
    J Surg Oncol. 2022;126:888-895.
    PubMed     Abstract available
    
    
    September 2022
28. BAINVOLL L, Mandelbaum RS, Worswick SD, Matsuo K, et al
    Anatomical location of melanoma: A gender-specific analysis.
    J Surg Oncol. 2022 Sep 29. doi: 10.1002/jso.27111.
    PubMed    
    
    
    
29. MCKINLEY SK, Brady MS
    Neoadjuvant therapy for melanoma: A critical appraisal.
    J Surg Oncol. 2022 Sep 19. doi: 10.1002/jso.27089.
    PubMed     Abstract available
    
    
    
30. LYNCH KT, Hu Y, Farrow NE, Song Y, et al
    Regional control after precision lymph node dissection for clinically evident melanoma metastasis.
    J Surg Oncol. 2022 Sep 17. doi: 10.1002/jso.27100.
    PubMed     Abstract available
    
    
    July 2022
31. STRAKER RJ, Tortorello GN, Sharon CE, Keele LJ, et al
    Association of type II diabetes mellitus with characteristics and outcomes for patients undergoing sentinel lymph node biopsy for cutaneous melanoma.
    J Surg Oncol. 2022 Jul 28. doi: 10.1002/jso.27021.
    PubMed     Abstract available
    
    
    
32. MARSH KM, Lattimore CM, Cramer CL, Slingluff CL Jr, et al
    Subcostal lymph nodes: An unusual sentinel lymph node basin in cutaneous melanoma.
    J Surg Oncol. 2022 Jul 23. doi: 10.1002/jso.27022.
    PubMed     Abstract available
    
    
    
33. SALIM DN, Obinah MPB, Ternov NK, McCullagh MJD, et al
    Fine needle and core needle ultrasound guided biopsies for assessing suspected melanoma metastasis in lymph nodes and subcutaneous tissue.
    J Surg Oncol. 2022 Jul 6. doi: 10.1002/jso.26998.
    PubMed     Abstract available
    
    
    March 2022
34. WHITMAN ED, Guenther JM
    RE: More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26775.
    PubMed    
    
    
    
35. YAN MK, Adler NR, Pan Y, Chamberlain A, et al
    Yield of baseline imaging for distant metastases in high-risk primary melanoma.
    J Surg Oncol. 2022 Mar 9. doi: 10.1002/jso.26846.
    PubMed     Abstract available
    
    
    
36. MATSUO K, Nishio S, Ogata D, Kato T, et al
    Treatment specialty-specific characteristics and outcomes in women with vulvo-vaginal melanoma: A JGOG-JSCS joint study.
    J Surg Oncol. 2022 Mar 3. doi: 10.1002/jso.26835.
    PubMed    
    
    
    
37. CHAN BKY, Carrion-Alvarez L, Telfer R, Rehman AH, et al
    Surgical management of suspected gallbladder cancer: The role of intraoperative frozen section for diagnostic confirmation.
    J Surg Oncol. 2022;125:399-404.
    PubMed     Abstract available
    
    
    
38. WITT RG, Cope B, Chiang YJ, Newhook T, et al
    Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy.
    J Surg Oncol. 2022;125:719-729.
    PubMed     Abstract available
    
    
    
39. ECKHOFF A, Farrow NE, Silvestri C, Stroobant E, et al
    How much time is enough? Sentinel lymph node mapping time depends on the radiotracer agent.
    J Surg Oncol. 2022;125:712-718.
    PubMed     Abstract available
    
    
    January 2022
40. SHARIB J, Slingluff CL Jr, Beasley GM
    Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines.
    J Surg Oncol. 2022;125:28-33.
    PubMed     Abstract available
    
    
    
41. FARIES MB
    Melanoma trials that defined surgical management.
    J Surg Oncol. 2022;125:34-37.
    PubMed     Abstract available
    
    
    
42. PATEL A, Skitzki J
    Melanoma trials that defined surgical management: Brief overview of current/upcoming adjuvant/neoadjuvant trials.
    J Surg Oncol. 2022;125:38-45.
    PubMed     Abstract available
    
    
    December 2021
43. YAN M, Rose PS, Houdek MT, Moran SL, et al
    Outcomes of the keystone perforator island flap for oncologic reconstruction of the back.
    J Surg Oncol. 2021;124:1002-1007.
    PubMed     Abstract available
    
    
    November 2021
44. JAEGER ZJ, Williams GA, Chen L, Mhlanga JC, et al
    (18) F-FDG positron emission tomography-computed tomography has a low positive predictive value for detecting occult recurrence in asymptomatic patients with high-risk Stages IIB, IIC, and IIIA melanoma.
    J Surg Oncol. 2021 Nov 6. doi: 10.1002/jso.26737.
    PubMed     Abstract available
    
    
    
45. RENTROIA-PACHECO B, Tjien-Fooh FJ, Quattrocchi E, Kobic A, et al
    Clinicopathologic models predicting non-sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node?
    J Surg Oncol. 2021 Nov 4. doi: 10.1002/jso.26736.
    PubMed     Abstract available
    
    
    October 2021
46. WEITEMEYER MB, Helvind NM, Brinck AM, Holmich LR, et al
    More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.
    J Surg Oncol. 2021 Oct 21. doi: 10.1002/jso.26723.
    PubMed     Abstract available
    
    
    September 2021
47. DUNNE JA, Adigbli G
    The changing landscape in management of desmoplastic melanoma.
    J Surg Oncol. 2021 Sep 17. doi: 10.1002/jso.26677.
    PubMed    
    
    
    
48. SUBRAMANIAN S, Han G, Olson N, Leong SP, et al
    Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival.
    J Surg Oncol. 2021 Sep 17. doi: 10.1002/jso.26678.
    PubMed     Abstract available
    
    
    
49. CORSINI EM, Mitchell KG, Zhou N, Bernatchez C, et al
    Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
    J Surg Oncol. 2021;124:699-703.
    PubMed     Abstract available
    
    
    August 2021
50. DOWNS JS, Subramaniam S, Henderson MA, Paton E, et al
    A survey of surgical management of the sentinel node positive melanoma patient in the post-MSLT2 era.
    J Surg Oncol. 2021 Aug 18. doi: 10.1002/jso.26641.
    PubMed     Abstract available
    
    
    July 2021
51. MULDER EEAP, Stahlie EHA, Verver D, Lemstra C, et al
    False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC).
    J Surg Oncol. 2021 Jul 8. doi: 10.1002/jso.26607.
    PubMed     Abstract available
    
    
    June 2021
52. NARANG J, Hue JJ, Bingmer K, Hardacre JM, et al
    Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
    J Surg Oncol. 2021 Jun 9. doi: 10.1002/jso.26565.
    PubMed     Abstract available
    
    
    
53. DECKERS EA, Kruijff S, Bastiaannet E, van Ginkel RJ, et al
    Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB.
    J Surg Oncol. 2021 Jun 4. doi: 10.1002/jso.26555.
    PubMed     Abstract available
    
    
    March 2021
54. LYNCH KT, Kane WJ, Fleming MA, Desai RP, et al
    Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
    J Surg Oncol. 2021 Mar 31. doi: 10.1002/jso.26478.
    PubMed     Abstract available
    
    
    
55. THOMAS D, Bello DM
    Adjuvant immunotherapy for melanoma.
    J Surg Oncol. 2021;123:789-797.
    PubMed     Abstract available
    
    
    February 2021
56. HUI JYC, Burke E, Broman KK, Marmor S, et al
    Surgeon decision-making for management of positive sentinel lymph nodes in the post-Multicenter Selective Lymphadenectomy Trial II era: A survey study.
    J Surg Oncol. 2021;123:646-653.
    PubMed     Abstract available
    
    
    December 2020
57. HOUDEK MT, Honig RL, Mallett KE, Moran SL, et al
    Utility of toe fillet flaps for reconstruct of the forefoot in cases of plantar melanoma.
    J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26348.
    PubMed    
    
    
    
58. BREDBECK BC, Mubarak E, Zubieta DG, Tesorero R, et al
    Management of the positive sentinel lymph node in the post-MSLT-II era.
    J Surg Oncol. 2020;122:1778-1784.
    PubMed     Abstract available
    
    
    November 2020
59. PINERO-MADRONA A, Nicolas-Ruiz F, Rull-Ortuno R, Vidal-Sicart S, et al
    Correlation between ferromagnetic and isotopic tracers for sentinel lymph node detection in cutaneous melanoma: IMINEM study.
    J Surg Oncol. 2020 Nov 25. doi: 10.1002/jso.26303.
    PubMed     Abstract available
    
    
    
60. YAMASHITA TS, Pockaj BA, Bagaria SP, Flotte TJ, et al
    Clinical significance of SLN benign capsular nevi in patients with melanoma.
    J Surg Oncol. 2020;122:1043-1049.
    PubMed     Abstract available
    
    
    October 2020
61. BLEICHER J, Swords DS, Mali ME, McGuire L, et al
    Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
    J Surg Oncol. 2020 Oct 24. doi: 10.1002/jso.26214.
    PubMed     Abstract available
    
    
    
62. LEE AY, Brady MS
    Neoadjuvant immunotherapy for melanoma.
    J Surg Oncol. 2020 Oct 1. doi: 10.1002/jso.26229.
    PubMed     Abstract available
    
    
    
63. FRANKE V, Madu MF, Bierman C, Klop WMC, et al
    Challenges in sentinel node pathology in the era of adjuvant treatment.
    J Surg Oncol. 2020;122:964-972.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.